GSK-1940029 | B2373

GSK-1940029 is a potent stearoyl-coA desaturase (SCD) inhibitor

GSK-1940029 is a potent stearoyl-coA desaturase (SCD) inhibitor

B2373 | GSK-1940029 DataSheet

Alternate Name/Synonyms: 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyltriazole-4-carboxamide, GSK1940029

Appearance: Crystalline solid

Formulation:

CAS Number: 1150701-66-8

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: N/A

Molecular Formula: C₁₈H₁₆Cl₂N₄O₂

Molecular Weight: 391.25

Cell-Permeable?: TRUE

Purity: ≥98%

Solubilities: >25 mg/ml in DMSO

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: A stearoyl-CoA desaturase (SCD) inhibitor

MDL Number:

PubChem CID: 42603008

SMILES: CC1=C(N=NN1CC2=CC(=C(C=C2)Cl)Cl)C(=O)NC3=CC=C(C=C3)CO

InChi: InChI=1S/C18H16Cl2N4O2/c1-11-17(18(26)21-14-5-2-12(10-25)3-6-14)22-23-24(11)9-13-4-7-15(19)16(20)8-13/h2-8,25H,9-10H2,1H3,(H,21,26)

InChi Key: QQRGSFYTPBYCFD-UHFFFAOYSA-N